JP2017528497A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528497A5 JP2017528497A5 JP2017516058A JP2017516058A JP2017528497A5 JP 2017528497 A5 JP2017528497 A5 JP 2017528497A5 JP 2017516058 A JP2017516058 A JP 2017516058A JP 2017516058 A JP2017516058 A JP 2017516058A JP 2017528497 A5 JP2017528497 A5 JP 2017528497A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- lap
- composition according
- acting parenteral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- QQLNTUQPJDWWEG-AKNSIARISA-N CC(C)C(C(C1)=O)=C(C(CC2)C(C)(CC3)C(C)(CC4)C2C(C)(CC2)C4C(C)(C)C2OC(CC(C)(C)C(O)=O)=O)C13C(CN(CCN(C)C)C/C(/C)=C/C=C(\C)/Cl)O Chemical compound CC(C)C(C(C1)=O)=C(C(CC2)C(C)(CC3)C(C)(CC4)C2C(C)(CC2)C4C(C)(C)C2OC(CC(C)(C)C(O)=O)=O)C13C(CN(CCN(C)C)C/C(/C)=C/C=C(\C)/Cl)O QQLNTUQPJDWWEG-AKNSIARISA-N 0.000 description 1
- WCWSTNLSLKSJPK-LKFCYVNXSA-N C[C@@H](CO[C@@H]1CN(C=C(C(NCc(ccc(F)c2)c2F)=O)C2=O)C3=C2O)N1C3=O Chemical compound C[C@@H](CO[C@@H]1CN(C=C(C(NCc(ccc(F)c2)c2F)=O)C2=O)C3=C2O)N1C3=O WCWSTNLSLKSJPK-LKFCYVNXSA-N 0.000 description 1
- 0 Cc1c(*(C(C=C*2)=*C2*(c(cc2)ccc2N)=C)=C)c(C)cc(C=CN)c1 Chemical compound Cc1c(*(C(C=C*2)=*C2*(c(cc2)ccc2N)=C)=C)c(C)cc(C=CN)c1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462055779P | 2014-09-26 | 2014-09-26 | |
| US62/055,779 | 2014-09-26 | ||
| PCT/IB2015/057360 WO2016046786A1 (en) | 2014-09-26 | 2015-09-24 | Long acting pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017528497A JP2017528497A (ja) | 2017-09-28 |
| JP2017528497A5 true JP2017528497A5 (enExample) | 2018-08-16 |
Family
ID=54256799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017516058A Withdrawn JP2017528497A (ja) | 2014-09-26 | 2015-09-24 | 長時間作用型医薬組成物 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10092523B2 (enExample) |
| EP (1) | EP3197430A1 (enExample) |
| JP (1) | JP2017528497A (enExample) |
| KR (1) | KR20170056702A (enExample) |
| CN (1) | CN106999425A (enExample) |
| AU (1) | AU2015323321A1 (enExample) |
| BR (1) | BR112017006005A2 (enExample) |
| CA (1) | CA2961528A1 (enExample) |
| CL (1) | CL2017000714A1 (enExample) |
| CR (1) | CR20170113A (enExample) |
| DO (1) | DOP2017000086A (enExample) |
| EA (1) | EA201790495A1 (enExample) |
| IL (1) | IL251337A0 (enExample) |
| MX (1) | MX2017003928A (enExample) |
| PE (1) | PE20170691A1 (enExample) |
| SG (1) | SG11201702379TA (enExample) |
| WO (1) | WO2016046786A1 (enExample) |
| ZA (1) | ZA201702086B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3387B1 (ar) | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
| MA38182A1 (fr) | 2012-12-14 | 2018-04-30 | Glaxosmithkline Llc | Compositions pharmaceutiques a action prolongée pur une utilisation dans le traitement ou la prévention d'infections par le virus de l’immunodéficience humaine (vih) |
| SG11201702379TA (en) | 2014-09-26 | 2017-04-27 | Glaxosmithkline Ip No 2 Ltd | Long acting pharmaceutical compositions |
| CA3005313C (en) * | 2015-11-16 | 2024-01-09 | Evonik Rohm Gmbh | Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide) |
| CN107184551B (zh) * | 2017-06-09 | 2020-09-01 | 甘肃新天马制药股份有限公司 | 一种利拉萘酯双粒径分布乳剂及其制备方法 |
| AU2018304591A1 (en) | 2017-07-21 | 2020-03-05 | Janssen Sciences Ireland Unlimited Company | Regimens for treating hiv infections and aids |
| MX2022006940A (es) * | 2019-12-09 | 2022-07-11 | Viiv Healthcare Co | Composiciones farmaceuticas. |
| CN115844838B (zh) * | 2022-12-01 | 2023-10-24 | 浙江萃泽医药科技有限公司 | 一种可注射的药物组合物 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8815265D0 (en) | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
| US5358721A (en) | 1992-12-04 | 1994-10-25 | Alza Corporation | Antiviral therapy |
| GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| EP1292562A1 (en) | 2000-05-23 | 2003-03-19 | Univerzita palackeho V Olomouci | Triterpenoid derivatives |
| DE10103810A1 (de) | 2001-01-29 | 2002-08-01 | Map Gmbh | Vorrichtung zur Zufuhr eines Atemgases |
| US7163700B2 (en) | 2001-07-31 | 2007-01-16 | Capricorn Pharma, Inc. | Amorphous drug beads |
| US8101629B2 (en) | 2001-08-13 | 2012-01-24 | Janssen Pharmaceutica N.V. | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| US7638522B2 (en) | 2001-08-13 | 2009-12-29 | Janssen Pharmaceutica N.V. | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile |
| JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
| US20080206161A1 (en) | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
| US20050142205A1 (en) | 2003-07-18 | 2005-06-30 | Julia Rashba-Step | Methods for encapsulating small spherical particles prepared by controlled phase separation |
| WO2005112929A2 (en) | 2004-05-20 | 2005-12-01 | Cornell Research Foundation, Inc. | Anti-hiv-1 activity of betulinol derivatives |
| US7150323B2 (en) | 2004-07-26 | 2006-12-19 | Vetco Gray Inc. | Shoulder ring set on casing hanger trip |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| WO2006105356A2 (en) | 2005-03-29 | 2006-10-05 | Regents Of The University Of Minnesota | Methods of manufacturing bioactive 3-esters of betulinic aldehyde and betulinic acid |
| TWI457136B (zh) | 2005-04-04 | 2014-10-21 | Tibotec Pharm Ltd | Ｈｉｖ-感染之預防 |
| WO2006117666A2 (en) | 2005-04-29 | 2006-11-09 | Pfizer Inc. | Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery |
| US20070197646A1 (en) | 2006-02-21 | 2007-08-23 | Achillion Pharmaceuticals, Inc. | Substituted taraxastanes useful for treating viral infections |
| FI121468B (fi) | 2006-06-07 | 2010-11-30 | Valtion Teknillinen | Betuliiniperäiset yhdisteet antimikrobisina aineina |
| HUE068406T2 (hu) * | 2006-06-23 | 2024-12-28 | Janssen Sciences Ireland Unlimited Co | A TMC278 vizes szuszpenziója |
| WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| AR063546A1 (es) | 2006-11-03 | 2009-01-28 | Panacos Pharmaceuticals Inc | DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH. |
| CN101977924A (zh) | 2008-01-03 | 2011-02-16 | Viro化学制药公司 | 新的c-21-酮基羽扇烷衍生物、其制备方法和应用 |
| WO2009082819A1 (en) | 2008-01-03 | 2009-07-09 | Virochem Pharma Inc. | Novel lupane derivatives |
| DE102008037025C5 (de) | 2008-08-08 | 2016-07-07 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform |
| US8778990B2 (en) | 2008-11-04 | 2014-07-15 | Trustees Of Dartmouth College | Betulinic acid derivatives and methods of use thereof |
| CZ301318B6 (cs) | 2008-11-13 | 2010-01-13 | Univerzita Palackého v Olomouci | 2-Deoxyglykosidy triterpenoidu, zpusob jejich prípravy a jejich použití jako lécivo |
| EP3210603A1 (en) | 2008-12-11 | 2017-08-30 | Shionogi & Co., Ltd | Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
| US8802727B2 (en) | 2009-07-14 | 2014-08-12 | Hetero Research Foundation, Hetero Drugs Limited | Pharmaceutically acceptable salts of betulinic acid derivatives |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| US20110051713A1 (en) | 2009-08-27 | 2011-03-03 | Xerox Corporation | Facsimile prioritization within internet protocol call networks |
| EA201290632A1 (ru) | 2010-02-11 | 2013-03-29 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Производные бетулина |
| TWI577377B (zh) | 2010-09-16 | 2017-04-11 | Ｖｉｉｖ醫療保健公司 | 醫藥組合物 |
| WO2013020246A1 (en) | 2011-08-08 | 2013-02-14 | Glaxosmithkline Llc | Methylene derivatives of betulin |
| WO2013020245A1 (en) | 2011-08-08 | 2013-02-14 | Glaxosmithkline Llc | Carbonyl derivatives of betulin |
| ES2584684T3 (es) | 2011-12-14 | 2016-09-28 | Glaxosmithkline Llc | Derivados de propenoato de betulina |
| JO3387B1 (ar) | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
| CN104844679B (zh) | 2011-12-16 | 2017-03-01 | 葛兰素史克有限责任公司 | 白桦脂醇的衍生物 |
| WO2014035945A1 (en) | 2012-08-28 | 2014-03-06 | Glaxosmithkline Llc | Pharmaceutical compositions |
| MA38182A1 (fr) | 2012-12-14 | 2018-04-30 | Glaxosmithkline Llc | Compositions pharmaceutiques a action prolongée pur une utilisation dans le traitement ou la prévention d'infections par le virus de l’immunodéficience humaine (vih) |
| SG11201702379TA (en) | 2014-09-26 | 2017-04-27 | Glaxosmithkline Ip No 2 Ltd | Long acting pharmaceutical compositions |
-
2015
- 2015-09-24 SG SG11201702379TA patent/SG11201702379TA/en unknown
- 2015-09-24 CA CA2961528A patent/CA2961528A1/en not_active Abandoned
- 2015-09-24 EP EP15775510.9A patent/EP3197430A1/en not_active Withdrawn
- 2015-09-24 KR KR1020177011108A patent/KR20170056702A/ko not_active Withdrawn
- 2015-09-24 CR CR20170113A patent/CR20170113A/es unknown
- 2015-09-24 EA EA201790495A patent/EA201790495A1/ru unknown
- 2015-09-24 MX MX2017003928A patent/MX2017003928A/es unknown
- 2015-09-24 AU AU2015323321A patent/AU2015323321A1/en not_active Abandoned
- 2015-09-24 WO PCT/IB2015/057360 patent/WO2016046786A1/en not_active Ceased
- 2015-09-24 CN CN201580062609.4A patent/CN106999425A/zh active Pending
- 2015-09-24 BR BR112017006005A patent/BR112017006005A2/pt not_active Application Discontinuation
- 2015-09-24 PE PE2017000515A patent/PE20170691A1/es not_active Application Discontinuation
- 2015-09-24 US US15/514,564 patent/US10092523B2/en not_active Expired - Fee Related
- 2015-09-24 JP JP2017516058A patent/JP2017528497A/ja not_active Withdrawn
-
2017
- 2017-03-22 IL IL251337A patent/IL251337A0/en unknown
- 2017-03-24 ZA ZA2017/02086A patent/ZA201702086B/en unknown
- 2017-03-24 DO DO2017000086A patent/DOP2017000086A/es unknown
- 2017-03-24 CL CL2017000714A patent/CL2017000714A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528497A5 (enExample) | ||
| JP2016503030A5 (enExample) | ||
| JP6231385B2 (ja) | 医薬組成物 | |
| AU2013358897B2 (en) | Pharmaceutical compositions | |
| US10092523B2 (en) | Long acting pharmaceutical compositions | |
| AU2020263285B2 (en) | Continuous delivery of lenalidomide and other immunomodulatory agents | |
| JP2010510241A5 (enExample) | ||
| KR102794804B1 (ko) | 서방형 팔리페리돈 주사용 제형과 관련된 투약 요법 | |
| FI3541366T3 (fi) | Exendiinin (9-39) puskuroidut formulaatiot | |
| RS62362B1 (sr) | Formulacije sa dugotrajnim dejstvom | |
| KR20230116837A (ko) | 서방형 팔리페리돈 주사용 제형과 관련된 투약 요법 | |
| RS65815B1 (sr) | Režimi doziranja povezani sa formulacijama za injektovanje paliperidona sa produženim oslobađanjem | |
| Tran et al. | Modulation of drug crystallization and molecular interactions by additives in solid dispersions for improving drug bioavailability | |
| JP2015504094A5 (enExample) | ||
| US20170312297A1 (en) | Long Acting Pharmaceutical Compositions For Hepatitis C | |
| RU2021102950A (ru) | Твердые фармацевтические композиции для лечения вируса гепатита с | |
| US10034865B2 (en) | Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof | |
| EP1796730B1 (en) | Stabilized leukotriene b4 (ltb4) agent pharmaceutical |